Embecta Corp. (EMBC)
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Last price
- $6.20
- As of
Kresmion compiles this page from EMBC's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Embecta Corp. (EMBC): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-08-07.
See the full EMBC dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for EMBC on one page. Preview it with sample data, then open it live with a free account.
Preview the EMBC dossierActive signals for EMBC
- mediumEARNINGS_BEAT
Q3-2026: Beat consensus by 107.2%, EPS $0.56 vs $0.2703 estimate
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +76% to EMBC (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +3883% to EMBC (2026Q2)
- mediumNEW_POSITION
Point72 Asset Management, L.P. new position in EMBC
- highINSTITUTIONAL_SURGE
RENAISSANCE TECHNOLOGIES LLC added +300% to EMBC (2026Q1)
FREE, NO ACCOUNT
Every signal on EMBC, as it fires
You are seeing 5 of 9 signals recorded on EMBC since 2026-05-29.
The five above landed across 3 days. The other 4 were recorded on 1 other days. 5 of the 9 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in EMBC (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLCCUSIP 29082K105 · 2026Q2 | $3.1M | 0.00% | , |
| D. E. Shaw & Co., Inc.CUSIP 29082K105 · 2026Q2 | $2.1M | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 29082K105 · 2026Q2 | $1.5M | 0.00% | , |
| Point72 Asset Management, L.P.CUSIP 29082K105 · 2026Q2 | $66K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, EMBC
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
EMBC against its peers
EMBC's operating margin of 22.4% ranks in the 85th percentile of 16 Medical Instruments & Supplies sub-industry peers, fiscal periods ending between 2025-06-30 and 2025-12-31.
| Metric | EMBC | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 1.1B USD | 35.4M USD | 90 | 14 |
| Gross margin | 62.6% | 57.7% | 66 | 15 |
| Operating margin | 22.4% | -12.2% | 85 | 16 |
| Net margin | 8.8% | -18.3% | 79 | 16 |
| Return on equity | n/a | -16.2% | n/a | 16 |
| P / E | 3.8x | n/a | n/a | 3 |
| 1 year | -53.6% | 4.3% | 21 | 11 |
Peers (17): SMTI, OSUR, NNNN, UTMD, AVR, ZJYL, KRMD, NYXH, STXS, MBOT, BLFS, POCI, NEPH, HBIO, MLSS, ICUI, STVN. Left out: PDEX (period gap), KMTS (period gap), AZTA (no annual filing), ZTEK (no annual filing), DXR (no annual filing), PLSE (no annual filing), OBOCY (no annual filing), MMED (period gap). Fiscal periods ending between 2025-06-30 and 2025-12-31. Every figure is one full fiscal year read from one annual filing (EMBC: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow EMBC on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to EMBC for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.